ALVO vs SHC: fair value comparison
Alvotech and Sotera Health Company · Updated 2026-10-19
ALVO's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, SHC currently ranks higher by quality score.
| ALVO | SHC | |
|---|---|---|
| Verdict | Awaiting full valuation | Fairly valued |
| Last price | $5.00 | $17.89 |
| 12-month range | $3.00–$8.40 | $13.13–$19.57 |
| Rank by discount to fair value | — | #49 of 108 Healthcare |
| Rank by quality score | #117 of 301 Healthcare | #116 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Low | High |
| Margin trend | Expanding | Stable |
| Revenue growth | High | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: ALVO fair value analysis · SHC fair value analysis